<unk>  is a vesicular monoamine transporter 2 (VMAT2) inhibitor that is FDA approved for the treatment of adults with tardive dyskinesia.   Common adverse reactions include somnolence.
Valbenazine
Brinzolamide
Etofenamate
Ranolazine
Methazolamide
Brotizolam
Benazepril
Benidipine